関連する実験動画

Updated: Sep 10, 2025

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

FAM111Bに関連したポイキロダーマとフェノタイプスペクトルの拡張におけるウビキチン-プロテアソームシステムの調節障害:新しい症例報告と長期追跡

Virginie Vignard¹, Mike Maillasson², Anne Bigot³

¹Nantes Université, CNRS, INSERM, l'institut du Thorax, Nantes 44000, France.

|August 21, 2025

まとめ

FAM111B変異によって引き起こされる遺伝性線維性疾患POIKTMPは,機能不全のユビキチン- プロテアソーム系 (UPS) を含む. この発見はPOIKTMP患者のための新しい治療目標を提供します.

科学分野:

遺伝学と分子生物学
珍しい病気
細胞生物学

背景:

遺伝性線維性ポイキロダーマ (POIKTMP) は,FAM111B遺伝子変異に関連した珍しい遺伝疾患である.
POIKTMPの背後にある分子メカニズムは十分に理解されていません.
FAM111Bはセリンプロテアゼであり,腫瘍と一貫して関連していない生殖系変異によって示されるように,がん以外の役割があります.

研究の目的:

POIKTMPの分子病原性を解明する
POIKTMPの臨床的スペクトルと遺伝的基礎の理解を広げること.

主な方法:

4人の新規症例を含む41人のPOIKTMP患者の臨床データを収集し,比較した.
機能的研究は,FAM111Bミセンセスの変種を持つ患者由来細胞でオミックスの技術を使用した.

主要な成果:

POIKTMPのフェノタイプには,腎不全,歯の異常,副副甲状腺症,神経症が含まれています.
Dボックス領域のFAM111B変異は,より重度の臨床表現と相関しています.
FAM111Bの発現が失われると,ユビキチン- プロテアソーム系 (UPS) が破壊され,ユビキチン- タンパク質結合体が増加し,I型インターフェロンシグネチャが誘発される.

結論:

機能不全のUPSは,POIKTMPの分子病原性における重要な要因であると考えられています.
これらの発見は,POIKTMPに対するUPS機能障害を標的とした潜在的な治療戦略を示唆する.

キーワード:

ケースレポート FAM111B オミックスポイキロダーマウビキチン-プロテアソーム系

さらに関連する動画

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

関連する概念動画

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

Pedigree Analysis

Pedigree Analysis

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

Protein Complexes with Interchangeable Parts

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...